Skip to main content
    • Aa
    • Aa

Hepatitis C prevalence in injecting drug users in Europe, 1990–2007: impact of study recruitment setting

  • M. RONDY (a1) (a2), L. WIESSING (a3), S. J. HUTCHINSON (a4) (a5), C. MATHEÏ (a6), F. MATHIS (a7), V. MRAVCIK (a8), L. NORDEN (a9), M. ROSIŃSKA (a10), O. SCUTELNICIUC (a11), B. SULIGOI (a12), F. VALLEJO (a13), M. VAN VEEN (a1) and M. KRETZSCHMAR (a1) (a14)...

Monitoring injecting drug users' (IDUs) health is challenging because IDUs form a difficult to reach population. We examined the impact of recruitment setting on hepatitis C prevalence. Individual datasets from 12 studies were merged. Predictors of HCV positivity were sought through a multilevel analysis using a mixed-effects logistic model, with study identifier as random intercept. HCV prevalence ranged from 21% to 86% across the studies. Overall, HCV prevalence was higher in IDUs recruited in drug treatment centres compared to those recruited in low-threshold settings (74% and 42%, respectively, P < 0·001). Recruitment setting remained significantly associated with HCV prevalence after adjustment for duration of injecting and recent injection (adjusted odds ratio 0·7, 95% confidence interval 0·6–0·8, P = 0·05). Recruitment setting may have an impact on HCV prevalence estimates of IDUs in Europe. Assessing the impact of mixed recruitment strategies, including respondent-driven sampling, on HCV prevalence estimates, would be valuable.

Corresponding author
*Author for correspondence: Mr M. Rondy, 90 rue d'Amsterdam, 75011 Paris, France. (Email:
Linked references
Hide All

This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.

3. GH Friedland , Intravenous drug abusers and the acquired immunodeficiency syndrome (AIDS) Demographic, drug use, and needle-sharing patterns. Archives of Internal Medicine 1985; 145: 14131417.

6. C Matheï , F Buntinx , P van Damme . Seroprevalence of hepatitis C markers among intravenous drug users in western European countries: a systematic review. Journal of Viral Hepatitis 2002; 9: 157173.

8. L Wiessing , Associations between availability and coverage of HIV prevention measures and subsequent incidence of diagnosed HIV infection among injection drug users. American Journal of Public Health 2009; 99: 10491052.

9. BM Mathers , for the 2009 Reference Group to the UN on HIV and Injecting Drug Use. HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage. Lancet 2010; 375: 10141028.

13. D Hedrich , A Pirona , L. Wiessing From margin to mainstream: the evolution of harm reduction responses to problem drug use in Europe. Drugs Education Prevention and Policy 2008; 15: 503517.

15. T Zabransky , Hepatitis C virus infection among injecting drug users in the Czech Republic – prevalence and associated factors. European Addiction Research 2006; 12: 151160.

17. L Camoni , , SerT Study Group.Continued high prevalence of HIV, HBV and HCV among injecting and noninjecting drug users in Italy. Annali dell'Istituto Superiore di Sanità 2010; 46: 5965.

18. L Camoni , , SerT Study Group.Prevalence and correlates of infection with human immunodeficiency virus, hepatitis B virus, and hepatitis C virus among drug users in Italy: a cross-sectional study. Scandinavian Journal of Infectious Diseases 2009; 41: 521523.

20. A Taylor , Prevalence of hepatitis C virus infection among injecting drug users in Glasgow 1990–1996: are current harm reduction strategies working? Journal of Infection 2000; 40: 176183.

21. SJ Hutchinson , Factors associated with injecting risk behaviour among serial community-wide samples of injecting drug users in Glasgow 1990–94: implications for control and prevention of blood-borne viruses. Addiction 2000; 95: 931–40.

23. SF Greenfield , Substance abuse treatment entry, retention, and outcome in women: a review of the literature. Drug and Alcohol Dependence 2007; 86: 121.

24. MT Schechter , Do needle exchange programmes increase the spread of HIV among injection drug users?: an investigation of the Vancouver outbreak. AIDS 1999; 13: F4551.

25. L Platt , Measuring risk of HIV and HCV among injecting drug users in the Russian Federation. European Journal of Public Health 2009; 19: 428433.

26. MJ Alter . Epidemiology of hepatitis C virus infection. World Journal of Gastroenterology 2007; 13: 24362441.

28. CE Lindenburg , Decline in HIV incidence and injecting, but not in sexual risk behaviour, seen in drug users in Amsterdam: a 19-year prospective cohort study. AIDS 2006; 20: 17711775.

32. AS Abdul-Quader , Effectiveness of respondent-driven sampling for recruiting drug users in New York City: findings from a pilot study. Journal of Urban Health 2006; 83: 459476.

33. D Heckathorn, Douglas . Respondent-driven sampling: a new approach to the study of hidden populations. Social Problems 1997; 44: 174199.

34. M Malekinejad , Accessing a diverse sample of injection drug users in San Francisco through respondent-driven sampling. Drug and Alcohol Dependence 2011; 118: 8391.

35. A Uusküla , Evaluating recruitment among female sex workers and injecting drug users at risk for HIV using respondent-driven sampling in Estonia. Journal of Urban Health 2010; 87: 304317.

36. AE Rudolph , Subpopulations of illicit drug users reached by targeted street outreach and respondent-driven sampling strategies: implications for research and public health practice. Annals of Epidemiology 2011; 21: 280289.

Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Epidemiology & Infection
  • ISSN: 0950-2688
  • EISSN: 1469-4409
  • URL: /core/journals/epidemiology-and-infection
Please enter your name
Please enter a valid email address
Who would you like to send this to? *



Full text views

Total number of HTML views: 1
Total number of PDF views: 6 *
Loading metrics...

Abstract views

Total abstract views: 107 *
Loading metrics...

* Views captured on Cambridge Core between September 2016 - 23rd June 2017. This data will be updated every 24 hours.